Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low‐Density Lipoprotein Cholesterol
Cardiovascular disease (CVD) is the leading cause of death in patients with nonalcoholic fatty liver disease (NAFLD). The current analysis expands the knowledge on atherogenic lipid profiles in NAFLD by modeling changes in low‐density lipoprotein cholesterol (LDL‐C) and total cholesterol (TC) in a p...
Main Authors: | Christian Labenz, Jürgen H. Prochaska, Yvonne Huber, Michael Nagel, Beate K. Straub, Philipp Wild, Peter R. Galle, Jörn M. Schattenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2019-11-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1428 |
Similar Items
-
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
by: Christian Labenz, et al.
Published: (2020-09-01) -
Hepatic interleukin‐1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver disease
by: Nadine Gehrke, et al.
Published: (2022-09-01) -
Estimated small dense low‐density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations
by: Hangkai Huang, et al.
Published: (2024-04-01) -
Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study
by: Xiao Yu Ren, et al.
Published: (2019-02-01) -
Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease
by: Cheng-Maw Ho, et al.
Published: (2019-04-01)